RESUMEN
Benzodiazepines (BDs) are used widely in clinical practice, due to their multiple pharmacological functions. In this study a dispersive nanomaterial-ultrasound assisted- microextraction (DNUM) method followed by high performance liquid chromatography (HPLC) was used for the preconcentration and determination of chlordiazepoxide and diazepam drugs from urine and plasma samples. Various parameters such as amount of adsorbent (mg: ZnS-AC), pH and ionic strength of sample solution, vortex and ultrasonic time (min), and desorption volume (mL) were investigated by fractional factorial design (FFD) and central composite design (CCD). Regression models and desirability functions (DF) were applied to find the best experimental conditions for providing the maximum extraction recovery (ER). Under the optimal conditions a linear calibration curve were obtained in the range of 0.005-10µgmL(-1) and 0.006-10µgmL(-1) for chlordiazepoxide and diazepam, respectively. To demonstrate the analytical performance, figures of merits of the proposed method in urine and plasma spiked with chlordiazepoxide and diazepam were investigated. The limits of detection of chlordiazepoxide and diazepam in urine and plasma were ranged from 0.0012 to 0.0015µgmL(-1), respectively.
Asunto(s)
Clordiazepóxido/análisis , Cromatografía Líquida de Alta Presión/métodos , Diazepam/análisis , Nanoestructuras , Clordiazepóxido/sangre , Clordiazepóxido/orina , Diazepam/sangre , Diazepam/orina , Humanos , Microscopía Electrónica de Transmisión , Difracción de Rayos XRESUMEN
We report on a case of repeated MDPV consumptions that resulted in severe psychosis and agitation prompting the concomitant abuse of benzodiazepines. A 27-year-old man was found irresponsive in his apartment and was brought to the emergency department (ED) of a local hospital. When in ED, he rapidly recovered and self-reported to have recently injected some doses of MDPV that he had bought in the Internet. He left the hospital without medical cares. 15 days after, he was again admitted to the same ED due to severe agitation, delirium and hallucinations, and reported the use of MDPV and pharmaceutical drugs during the preceding week. He was sedated with diazepam and chlorpromazine. Urine samples collected in both occasions were sent for testing using liquid chromatography-high resolution mass spectrometry (LC-HRMS) and liquid chromatography-high resolution multiple mass spectrometry (LC-HRMS/MS) on an Orbitrap. The LC-HRMS analysis revealed the presence of MDPV and its phase I and phase II metabolites (demethylenyl-MDPV, demethylenyl-methyl-MDPV, demethylenyl-methyl-oxo-MDPV, demethylenyl-hydroxy-alkyl-MDPV, demethylenyl-methyl-hydroxy alkyl-MDPV, demethylenyl-oxo-MDPV and their corresponding glucuronides), alprazolam and alprazolam metabolite at the first ED admission; at the time of the second ED access, the same MDPV metabolites, alprazolam, temazepam, and chlordiazepoxide were detected together with diazepam and metabolites. LC-HRMS/MS was use to determine the following concentrations, respectively on his first and second admission: MDPV 55ng/mL, alprazolam 114ng/mL, α-hydroxyalprazolam 104ng/mL; MDPV 35ng/mL, alprazolam 10.4ng/mL, α -hydroxyalprazolam 13ng/mL; chlordiazepoxide 13ng/mL, temazepam 170ng/mL, diazepam 1.3ng/mL, nordiazepam 61.5, oxazepam 115ng/mL. The toxicological findings corroborated the referred concomitant use of multiple pharmaceutical drugs and benzodiazepines. Confirmation of previous hypothesis on human metabolism of MDPV could be inferred by the analysis of urine.
Asunto(s)
Benzodiazepinas/orina , Benzodioxoles/orina , Psicotrópicos/orina , Pirrolidinas/orina , Adulto , Alprazolam/análogos & derivados , Alprazolam/orina , Clordiazepóxido/orina , Cromatografía Liquida , Diazepam/orina , Humanos , Hipnóticos y Sedantes/orina , Masculino , Espectrometría de Masas/métodos , Nordazepam/orina , Oxazepam/orina , Trastornos Relacionados con Sustancias/orina , Temazepam/orina , Cathinona SintéticaRESUMEN
A simple, rapid, and sensitive method based on dispersive liquid-liquid microextraction combined with HPLC-UV detection applied for the quantification of chlordiazepoxide in some real samples. The effect of different extraction conditions on the extraction efficiency of the chlordiazepoxide drug was investigated and optimized using central composite design as a conventional efficient tool. Optimum extraction condition values of variables were set as 210 µL chloroform, 1.8 mL methanol, 1.0 min extraction time, 5.0 min centrifugation at 5000 rpm min(-1), neutral pH, 7.0% w/v NaCl. The separation was reached in less than 8.0 min using a C18 column using isocratic binary mobile phase (acetonitrile/water (60:40, v/v)) with flow rate of 1.0 mL min(-1) The linear response (r(2) > 0.998) was achieved in the range of 0.005-10 µg mL(-1) with detection limit 0.0005 µg mL(-1) The applicability of this method for simultaneous extraction and determination of chlordiazepoxide in four different matrices (water, urine, plasma, and chlordiazepoxide tablet) were investigated using standard addition method. Average recoveries at two spiking levels were over the range of 91.3-102.5% with RSD < 5.0% (n = 3). The obtained results show that dispersive liquid-liquid microextraction combined with HPLC-UV is a fast and simple method for the determination of chlordiazepoxide in real samples.
Asunto(s)
Ansiolíticos/análisis , Ansiolíticos/aislamiento & purificación , Clordiazepóxido/análisis , Clordiazepóxido/aislamiento & purificación , Cromatografía Líquida de Alta Presión/métodos , Microextracción en Fase Líquida/métodos , Ansiolíticos/sangre , Ansiolíticos/orina , Clordiazepóxido/sangre , Clordiazepóxido/orina , Cromatografía Líquida de Alta Presión/instrumentación , Humanos , Límite de Detección , Contaminantes Químicos del Agua/análisisRESUMEN
The analysis of mixture of benzodiazepine derivates (chlordiazepoxide, flunitrazepam, medazepam, nitrazepam, oxazepam and tetrazepam) by gas--liquid chromatography (GLC) in purpose to separate and identify these psychotropic drugs in mixture is presented in this article. The experiment was carried out in vitro, accommodating this method for identification and separation of drugs, isolated from biological objects (blood and urine). Referring to data of annual reports of chemical investigations (1) above-mentioned psychotropic drugs are very frequent among drug intoxication. In most cases they are detected in the mixture of the same or different pharmacological group, and this causes difficulty for separation and identification. The analysis of the mixture was carried out by GLC, which is widely used in practice of forensic-chemical examination. Adsorbents and stationery phases were changed; the conditions and parameters of chromatography were modified, in purpose totally separate preparations in the mixture. For the separation and identification of all three preparation the column packed with Inerton Super with stationary phase 3% OV-17 is suitable. The column temperature-290 degrees C. The mixture of these drugs was excreted from body fluids (blood and urine) in vitro and investigated by GLC under these conditions. The results of investigation were similar.
Asunto(s)
Ansiolíticos/análisis , Benzodiazepinas/análisis , Cromatografía de Gases/métodos , Ansiolíticos/sangre , Ansiolíticos/orina , Benzodiazepinas/sangre , Benzodiazepinas/orina , Clordiazepóxido/sangre , Clordiazepóxido/orina , Flunitrazepam/sangre , Flunitrazepam/orina , Humanos , Medazepam/sangre , Medazepam/orina , Modelos Teóricos , Nitrazepam/sangre , Nitrazepam/orina , Oxazepam/sangre , Oxazepam/orinaRESUMEN
Venlafaxine (V) is a second-generation antidepressant approved for use in the United States in 1993. It is a derivative of phenethylamine and is structurally unrelated to first- and other second-generation antidepressants. Nevertheless, its mechanism of action is similar to other antidepressants; it inhibits the reuptake of presynaptic norepinephrine and serotonin. Its major routes of elimination involve O and N demethylation. O-Desmethylvenlafaxine (ODV) is biologically active. Therapeutic concentrations of V and ODV are approximately 0.2 and 0.4 mg/L, respectively. Three cases of drug intoxication involving V are presented. V and ODV were identified by gas chromatography-nitrogen-phosphorus detection after alkaline extraction of the biological specimen. On an HP-5 column, V and ODV elute after bupropion and fluoxetine, but prior to the first-generation antidepressants, sertraline, amoxapine, and trazodone. V and ODV were confirmed by full scan electron impact gas chromatography-mass spectrometry. The heart-blood V and ODV concentrations (mg/L) in the three cases were 6.6 and 31; 84 and 15; and 44 and 50, respectively. In Case 1, acetaminophen and diphenhydramine were found in the heart blood at 140 and 2.6 mg/L respectively. In Case 2, amitriptyline, nortriptyline, and chlordiazepoxide were found in the blood at 2.8, 0.5 and 3.3 mg/L, respectively. In each case, the manner of death was suicide.
Asunto(s)
Antidepresivos de Segunda Generación/sangre , Ciclohexanoles/sangre , Inhibidores Selectivos de la Recaptación de Serotonina/sangre , Acetaminofén/sangre , Acetaminofén/metabolismo , Acetaminofén/orina , Adulto , Amitriptilina/sangre , Amitriptilina/metabolismo , Amitriptilina/orina , Antidepresivos de Segunda Generación/metabolismo , Antidepresivos de Segunda Generación/orina , Bilis/metabolismo , Clordiazepóxido/sangre , Clordiazepóxido/metabolismo , Clordiazepóxido/orina , Cromatografía de Gases , Ciclohexanoles/metabolismo , Ciclohexanoles/orina , Difenhidramina/sangre , Difenhidramina/metabolismo , Difenhidramina/orina , Humanos , Riñón/metabolismo , Hígado/metabolismo , Masculino , Metilación , Persona de Mediana Edad , Nortriptilina/sangre , Estándares de Referencia , Suicidio , Clorhidrato de VenlafaxinaRESUMEN
Urinary glucuronide metabolites of the benzodiazepines were converted back to the parent molecules after treatment with B-glucuronidase. The benzodiazepines were extracted by a one-step liquid/liquid extraction from urine or by a liquid/solid phase extraction. For the limit of detection (LOD), a standard solution of diazepam and oxazepam was serially diluted and analyzed to the point at which a reproducible analytical result was no longer obtained. Using a temperature program and a splitless mode of injection, excellent quantitation was achieved within an 8-min run time. Based upon specimens obtained from patients under a physician's care, we have determined that urinary concentrations of the benzodiazepines > 200 ng/ml are most likely due to abuse rather than to a prescribed ingestion under strict medical surveillance. Therefore, the calibration standard and cutoff concentration for a positive result was set at 200 ng/ml.
Asunto(s)
Benzodiazepinas/orina , Cromatografía de Gases y Espectrometría de Masas/métodos , Glucuronidasa , Alprazolam/orina , Clordiazepóxido/orina , Clonazepam/orina , Diazepam/orina , Humanos , Lorazepam/orina , Oxazepam/orina , Triazolam/orinaRESUMEN
We evaluated the EMIT (enzyme-multiplied immuno technique) and FPIA (fluorescence polarization immunoassay) urine screening systems for detection of benzodiazepine intake. Healthy male volunteers were given single oral therapeutic doses of alprazolam (2 mg), chlordiazepoxide (25 mg), flunitrazepam (1 mg), lorazepam (3.75 mg), nitrazepam (5 mg), and triazolam (0.25 mg), after which urine was collected for the next 32 h. The EMIT method failed to detect the intake of flunitrazepam, lorazepam, and nitrazepam. FPIA did not detect the intake of chlordiazepoxide, flunitrazepam, lorazepam, nitrazepam, and triazolam. Modification of the EMIT method to include enzymatic hydrolysis did not significantly alter the results obtained with this method. A modification of the FPIA method to include enzymatic hydrolysis and a lower cutoff value improved the results considerably, so that we reliably detected all studied substances but flunitrazepam. We conclude that (a) both EMIT and FPIA techniques, when used as intended by the manufacturers, are unreliable for the detection of intake of therapeutic doses of these benzodiazepines, and (b) the described modification of the FPIA should provide a much improved tool for detection of benzodiazepine intake.
Asunto(s)
Benzodiazepinas/orina , Inmunoensayo de Polarización Fluorescente/normas , Técnicas para Inmunoenzimas/normas , Adulto , Alprazolam/farmacocinética , Alprazolam/orina , Clordiazepóxido/farmacocinética , Clordiazepóxido/orina , Reacciones Falso Negativas , Flunitrazepam/farmacocinética , Flunitrazepam/orina , Humanos , Lorazepam/farmacocinética , Lorazepam/orina , Masculino , Persona de Mediana Edad , Nitrazepam/farmacocinética , Nitrazepam/orina , Triazolam/farmacocinética , Triazolam/orinaRESUMEN
A simple, isocratic, reversed-phase, high-pressure liquid chromatographic procedure was developed for the determination of chlordiazepoxide and its major metabolites in plasma and urine. The within-run coefficient of variation was 3.4-8.0%, and the day-to-day variation was 4.0-8.0%. Recoveries of 80-91% with sensitivity limits of 50 ng/ml were obtained for the parent drug and its metabolites. Plasma and urine samples collected after single intravenous and single oral doses were analyzed using this procedure.
Asunto(s)
Clordiazepóxido/análisis , Clordiazepóxido/sangre , Clordiazepóxido/orina , Cromatografía Líquida de Alta Presión , MétodosRESUMEN
1. The metabolism and plasma kinetics of chlordiazepoxide have been determined in a group of volunteers and in a group of patients with acute alcohol intoxication. 2. Using the SAAM 26 non-linear least squares fitting programme, all chlordiazepoxide plasma concentration v time data following oral administration could be analysed in terms of a one-compartment open model with metabolic conversion of chlordiazepoxide to desmethylchlordiazepoxide. 3. Acutely intoxicated patients showed a prolonged elimination of chlordiazepoxide and a reduced clearance when compared with alcohol-free volunteers. The elimination of desmethylchlordiazepoxide, on the other hand, appeared to be faster in the alcoholics. 4. Alcohol exerts significant effects on the metabolism of chlordiazepoxide in acutely intoxicated patients.
Asunto(s)
Intoxicación Alcohólica/metabolismo , Clordiazepóxido/metabolismo , Adulto , Anciano , Clordiazepóxido/sangre , Clordiazepóxido/orina , Remoción de Radical Alquila , Semivida , Humanos , Cinética , Masculino , Persona de Mediana Edad , Factores de TiempoRESUMEN
Chlordiazepoxide and its 4 major metabolites were assayed after separation by thin-layer chromatography following extraction from biological fluids. The compounds become intensely fluorescent in the presence of red, fuming nitric acid. The resulting compounds are quantitated with a spectrodensitometer with a fluorescent attachment. The sensitivity varies between 0.05 and 0.1 microgram. The coefficient of variation is 1.4% for assays in urine and 6.4% in serum.
Asunto(s)
Clordiazepóxido/análisis , Benzodiazepinonas/sangre , Benzodiazepinonas/orina , Clordiazepóxido/análogos & derivados , Clordiazepóxido/sangre , Clordiazepóxido/orina , Cromatografía en Capa Delgada , Humanos , Nordazepam/sangre , Nordazepam/orina , Oxazepam/sangre , Oxazepam/orina , Espectrometría de FluorescenciaRESUMEN
Three extraction procedures for the detection of diazepam, oxazepam, chlorazepate and/or chlordiazepoxide in human urines are presented. All three procedures are based on the acid hydrolysis of benzodiazepines and/or their conjugated metabolites to give the corresponding benzophenones. Procedure I involves the direct acid hydrolysis of raw urine and is recommended when the aim is to test the abuse of benzodiazepine derivatives only. Procedure II Is a two-step extraction method in which a wide variety of drugs of abuse including cocaine (test based on the detection of benzoylecgonine) are extracted by the first step using paper loaded with cation-exchange resin and the benzodiazepines are tested in the second step by the acid hydrolysis of the spent urine left after removing the ion-exchange paper. Procedure III involves the use of inert fibrous matrix and then its acid hydrolysis. The detection procedure is based on the identification of methylaminochlorobenzophenone (MACB) and aminochlorobenzophenone (ACB). MACB is detected as a yellow-colored compound while ACB is detected by spraying with Bratton-Marshall reagent. Specificity of detection of ACB has been achieved by the selection of a thin-layer developing solvent system in which sulfonamides with primary aromatic amino groups remain at the origin.